{{ navItem.description }}
{{ child.description }}
Successful Treatment of Refractory Cutaneous Protothecosis with MAT2203 Open Forum Infectious Diseases
Oral Lipid Nanocrystal Amphotericin B for the Treatment of Invasive Fungal Infections Open Forum Infectious Diseases
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial Clinical Infectious Disease
Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis Antimicrobial Agents and Chemotherapy
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B Antimicrobial Agents and Chemotherapy
Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis Therapeutics and Prevention
Intracellular Delivery of Small Oligonucleotides with Lipid Nanocrystals (LNCs): in vitro studies TIDES USA 2024
Successful in-vivo oral delivery of biologically active and therapeutic anti-inflammatory mRNA-targeted oligonucleotides with a lipid nanocrystal (LNC) delivery platform ASCGT 2024
Lipid Nanocrystal Delivery of siRNA: Dynamics of Uptake in Innate Immune Cells in Human Blood and Visualization of Small Oligonucleotide Delivery in Cell Culture ASGCT 2024 Oral Presentation
Oral Delivery of Anti-inflammatory Small Oligonucleotides with Lipid Nanocrystals UMASS RNAi Conference 2024
